Early research (Phase 1)Ended earlyNCT03818165
What this trial is testing
Phase 1b Study of CAR2Anti-CEA CAR-T Cell Hepatic Infusions for Pancreatic Carcinoma Patients With CEA+ Liver Metastases
Who this might be right for
Metastatic Pancreatic Carcinoma
Sorrento Therapeutics, Inc. 2